Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian MetastasesAnne Montfort, Oliver Pearce, Eleni Maniati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2019
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease LethalityGovindarajan Thangavelu, Yu-Chi Lee, Michael Loschi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2022
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer PatientsAlina M Hamilton, Amber N Hurson, Linnea T Olsson, et al.
The Journal of Clinical Investigation|August 22, 2017
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancerNicholas A Taylor, Sarah C Vick, Michael D Iglesia, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 24, 2021
Protein-based immune profiles of basal-like vs. luminal breast cancersAndrea Walens, Linnea T Olsson, Xiaohua Gao, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Nature Nanotechnology|June 27, 2017
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapyYuanzeng Min, Kyle C Roche, Shaomin Tian, et al.
Nature|October 27, 2017
Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiationSong Zhang, Motoki Takaku, Liyun Zou, et al.
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Cancer Immunology, Immunotherapy : CII|June 9, 2004
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancerE Claire Dees, Karen P McKinnon, Jennifer J Kuhns, et al.
Pageof 13